Immune (gamma) interferon production by a murine T cell lymphoma: requirements for macromolecular synthesis and lack of relationship with cell cycle.
Journal Article
Macromolecular synthesis of immune interferon (IFN-gamma) by the L12-R4 T cell lymphoma, stimulated by phorbol myristic acetate, was studied by using reversible inhibitors of protein synthesis, puromycin and cycloheximide, and an irreversible inhibitor of RNA synthesis, actinomycin D. Reversible inhibition of protein synthesis during the first 3 h of stimulation had no effect on IFN-gamma production. The same treatment, performed 4 h after stimulation and maintained for an additional 5 h, decreased significantly the capability of L12-R4 cells to produce IFN-gamma. When the inhibitors of protein synthesis were left in the cultures, a complete block of IFN-gamma production was observed. Irreversible inhibitors of RNA synthesis at the beginning of stimulation did block IFN-gamma production by L12-R4 cells, but the same treatment was ineffective if performed 6 h after stimulation. These data suggest that continued protein synthesis is needed for IFN-gamma production, whereas the RNA seems to be completely synthesized within 4 to 6 h of stimulation. The relationship between IFN-gamma production and cell cycle phases was studied with the aid of a reversible drug, aphidicolin, that arrests cells at the G1/S border. Phorbol myristic acetate stimulation of L12-R4 cells after aphidicolin removal induced comparable levels of IFN-gamma at each different point of stimulation, indicating that IFN-gamma production by stimulated cells is not related to a particular phase but is continuously inducible during the cell cycle.
Full Text
Duke Authors
Cited Authors
- Sarzotti, M; Landolfo, S; Dianzani, F
Published Date
- August 1983
Published In
Volume / Issue
- 41 / 2
Start / End Page
- 624 - 630
PubMed ID
- 6192085
Pubmed Central ID
- 6192085
International Standard Serial Number (ISSN)
- 0019-9567
Digital Object Identifier (DOI)
- 10.1128/IAI.41.2.624-630.1983
Language
- eng
Conference Location
- United States